Correlation Between NYSE Composite and Paratek Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Paratek Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Paratek Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Paratek Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Paratek Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Paratek Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Paratek Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Paratek Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Paratek is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Paratek Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paratek Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Paratek Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paratek Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Paratek Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Paratek Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 4.9 times less return on investment than Paratek Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 8.65 times less risky than Paratek Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Paratek Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 193.00 in Paratek Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 25.00 from holding Paratek Pharmaceuticals or generate 12.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 30.91% |
| Values | Daily Returns |
NYSE Composite vs. Paratek Pharmaceuticals
Performance |
| Timeline |
NYSE Composite and Paratek Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Paratek Pharmaceuticals
Pair trading matchups for Paratek Pharmaceuticals
Pair Trading with NYSE Composite and Paratek Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Paratek Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Paratek Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paratek Pharmaceuticals will offset losses from the drop in Paratek Pharmaceuticals' long position.| NYSE Composite vs. Lindblad Expeditions Holdings | NYSE Composite vs. LB Foster | NYSE Composite vs. HUTCHMED DRC | NYSE Composite vs. Bridgford Foods |
| Paratek Pharmaceuticals vs. Corvus Pharmaceuticals | Paratek Pharmaceuticals vs. Immutep Ltd ADR | Paratek Pharmaceuticals vs. Lyra Therapeutics | Paratek Pharmaceuticals vs. Equillium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |